White Paper | Modernizing The FDA Biomarker Qualification Program Strengthening Regulatory Clarity And Broadening Biomarker Use In Drug Development | June 2, 2026 Share
Issue Brief | Regulatory and Operational Considerations for Cell-Based Therapies | April 28, 2026 Share
White Paper | Leveraging AI-Enabled Tumor Assessment Tools on Radiological Images to Evaluate Treatment Effect and Support Clinical Trial Endpoints in Solid Tumors | January 26, 2026 Share
White Paper | Multi Regional Clinical Trials Addressing Standard Of Care Variability | October 28, 2025 Share
White Paper | Assessing Contribution Of Effect (COE) In Oncology Combination Therapies Lessons Learned To Inform And Optimize Future Registrational Trial Designs | October 28, 2025 Share
White Paper | Seamless Clinical Trial Designs in Rare Cancers Leveraging Operational and Adaptive Strategies to Accelerate Drug Development | October 28, 2025 Share
White Paper | Considerations for Leveraging Real-World Endpoints in Oncology Drug Development | August 21, 2025 Share
White Paper | Regulatory and Manufacturing Pathways to Expand Access to Genetically Modified Cell Based Therapies | May 8, 2025 Share
White Paper | Innovative Validation And Regulatory Processes For Companion Diagnostic Tests For Rare Biomarkers Or Indications | January 28, 2025 Share
Discussion Document | Considerations For Developing Reference Data Sets For Digital Pathology Biomarkers | January 28, 2025 Share
